Education

Fellowship
Neurology, UCLA School of Medicine, 2000
Residency
Neurology, UCLA School of Medicine, 1998
Internship
Internal Medicine, UCLA School of Medicine, 1995
Degree
MD, UCLA School of Medicine, 1994

Medical Board Certifications

Neurology
American Board of Psychiatry and Neurology, 2000

State License

A55356
  • About Me

    About Me

    Specializing in the care of patients with dementia, memory disorders, and neurocognitive decline.

    Director of Clinical Program
    UCLA Mary S. Easton Alzheimer's Disease Research Program

    Links

  • Locations
    Address
    100 UCLA Medical Plaza
    Suite 425
    Los Angeles, California 90095
    Phone
    310-794-6039
    Fax
    310-794-7491
  • Education

    Medical Board Certifications

    Neurology
    American Board of Psychiatry and Neurology, 2000

    Education

    Fellowship
    Neurology, UCLA School of Medicine, 2000
    Residency
    Neurology, UCLA School of Medicine, 1998
    Internship
    Internal Medicine, UCLA School of Medicine, 1995
    Degree
    MD, UCLA School of Medicine, 1994
  • Clinical Interests
    • Alzheimer's Disease
    • Cognitive
    • Memory Disorders
  • Research

    Research Interests

    Alzheimer's disease (interest area in the immunological aspects of Alzheimer’s disease)

    Publications

    1. Sleep, Cognition and Dementia. Porter VR, Buxton WG, Avidan AY. Curr Psychiatry Rep. 2015 Dec;17(12):97. doi: 10.1007/s11920-015-0631-8. PMID: 26478197
    2. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Mar 24. PMID: 25805829
    3. A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman. Ting SK, Benzinger T, Kepe V, Fagan A, Coppola G, Porter V, Hecimovic S, Chakraverty S, Alvarez-Retuerto AI, Goate A, Ringman JM. J Alzheimers Dis. 2014;40(2):271-5. doi: 10.3233/JAD-131844. PMID: 24413619 Free PMC
    4. A trial of imaging selection and endovascular treatment for ischemic stroke. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL; MR RESCUE Investigators. N Engl J Med. 2013 Mar 7;368(10):914-23. doi: 10.1056/NEJMoa1212793. Epub 2013 Feb 8. PMID: 23394476
    5. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebocontrolled study. Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. Alzheimers Res Ther. 2012 Oct 29;4(5):43. doi: 10.1186/alzrt146. eCollection 2012. PMID: 23107780 Free PMC Article
    6. Agitation and psychosis associated with dementia with Lewy bodies exacerbated by modafinil use. Prado E, Paholpak P, Ngo M, Porter V, Apostolova LG, Marrocos R, Ringman JM. Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):468-73. doi: 10.1177/1533317512456450. Epub 2012 Aug 14. Review. PMID: 22892657
    7. Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy. Fiala M, Porter V. Biomark Med. 2011 Oct;5(5):645-7. doi: 10.2217/bmm.11.64. No abstract available. PMID: 22003913 Free Article
    8. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids. Fiala M, Mahanian M, Rosenthal M, Mizwicki MT, Tse E, Cho T, Sayre J, Weitzman R, Porter V. J Alzheimers Dis. 2011;25(1):135-44. doi: 10.3233/JAD-2011-101950. PMID: 21368380
  • News & Awards

    In the News

    UCLA Headlines (UCLA's Office of Media Relations)
    Tuesday, Dec. 13, 2005:
    In the News: In relation to: Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood of male patients with mild Alzheimer’s disease and healthy elderly men. Archives of Neurology. 2006 Feb; 63(2):177-85. Epub 2005 Dec 12.

    ALZHEIMER'S: Research into testosterone therapy for men with Alzheimer's disease led by Po Lu, assistant clinical professor of neurology at the UCLA Alzheimer Disease Center, received coverage today from BBC News,
    Asian News International (India), Ivanhoe Newswire and DeHavilland Information Services (U.K.); and was featured Monday by Health Day News, United Press International, WebMD, CNN Radio and NBC News Channel.  Web coverage of the news release and wire reports included WebIndia123.com, MonstersAndCritics.com, ScienceDaily.com, NewKerala.com (India), HealthCentral.com, AJC.com, Statesman.com and Innovations-Report.com (Germany).

    Awards

    • Fellow in the American Neurological Association (FANA) I since 2013. This distinguished title is awarded to individuals who have attained the rank of Associated Clinical Professor, and who have made contributions that have enriched the field of neurology which attests to the nominee’s ability as an investigator and educator whose work has clear implications for neurological disease.
    • Subspecialty board certification (United Council of Neurologic Subspecialties) in Behavioral Neurology and Neuropsychiatry (November 2012-November, 2022; certification: BNNP00494-12).
    • Listed (2011-2016 editions) in the Southern California Super Doctors, Los Angeles Magazine (features top five percent of doctors in Los Angeles and Orange counties) superdoctors.com.
    • Dr. Porter also appeared in the 2010-2015 editions of the Los Angeles Magazine, Top Doctors. She was also selected as a Top Neurologist in Santa Monica, CA by the International Association of Healthcare Professionals (IAHCP) (2011-2015) in addition to inclusion in Top Women Southern California Super Doctors (2011-2016). I have also been named as a Leading Physician in the World (2011-2016) by the International Association of HealthCare Professionals (IAHCP) which is comprised of over 100 different medical societies.